Member Info for PJT12

Apologies if highlighted previously:

8 mins 56 secs

https://www.**********.co.uk/articles/paul-hill-on-stocks-valuations-russ-mould-on-banks-jamie-constable-on-the-macro-outlook-b98117d

Bottmzup, what do you think the SP will be at if the cancer delivery trials and all of the other therapeutics trials turn out as is hoped? You seem solely focused on the LFT for reasons known to yourself - and us.

Oops, sorry Tyche. That is meant for BU.

@tyche, the market doesn't agree with you.
April 23 2020 78p
April 23 2021 £2.36

Come back in December and we can compare again.

PL75, your reply to Mark wasn't missed here. Concise, effective and deserved.

I was too embarrassed to ask yesterday but 'What the hell?' I can't be the only thickie on here:

IND Filing means the filing of an Investigational New Drug Application (as defined in 21 C.F.R. 312 or any successor regulation) with the FDA or the equivalent application or filing filed with any equivalent agency or governmental authority in the European Union necessary to commence human clinical trials in such jurisdiction.

Just do a search for "Kimberley Thonger" if you can't see the link.

Chrisbak, you are correct in as much as someone with the right contacts is obviously helpful.

https://www.dailymail.co.uk/news/article-9438727/Two-firms-supplying-kits-Governments-mass-Covid-testing-drive-huge-payday.html

https://uk.linkedin.com/in/kim-thonger-8898307

Don't you mean you "hope" it shocked us? And please don't insult our intelligence by suggesting that we are blinkered to events elsewhere in the market.

In this order:

1. You don't need to swab your brain.
2. LFT's ARE HIGHLY RELIABLE if originating from Yorkshire where everything's done proper.

?

Good for NCYT......but will they have their initial data from a highly specific cancer tumor drug delivery system - with minimal side fx - by the end of Q4.

Zoom, I've been thinking about their PR people and, based upon their activities to date, feel that they are only being paid to provide the basic option IE RNS wording / layout etc. I don't think they are leaning towards the more active publicity role which would obviously cost more.

He's from Yorkshire.......string vest and some sturdy braces.

From Presentation

That was meant for Kamakiriad.

No, the reason you are seen as deramping is because you asked for Market Cap and investment justification, were sent documentation in response to your request and then were very clearly not interested in reading (hearing?) it.

Kamakiriad, you read that investment justification you asked for and I sent you earlier? Thought not. Try not to be so transparent with your deramping agenda because you ain't big and you ain't clever - but you are late to the party, evidently.

Bottmzup, surely not if you are basing it upon the Therapeutics potential too? That will smack a market cap of £609m out of the ballpark.

Kamakiriad, I gave you a whole raft of additional 'investment justification' documentation which you clearly were not genuinely interested in reading. That tells me everything I need to know about you.